Investors
Investor News
- Board and Executive Leadership Changes
- Shares Admitted to Trading on Asset Match
- John Bradshaw appointed as independent Non-Executive Director
- Update on trading post cancellation
- Result of General Meeting, Cancellation and Re-registration
- Proposed cancellation of admission of Ordinary Shares to trading on AIM
- Martin Murphy appointed as Non-Executive Director
- Result of General Meeting and Total Voting Rights
- £18 million raised to fund Phase 2 INVENT clinical trial of SNG001 in ventilated patients with severe viral lung infections